A major breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of tumors, https://wildbookmarks.com/story22152212/nanobodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-treatment